AGF Investments LLC’s Maravai LifeSciences MRVI Stock Holding History

AGF Investments LLC’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,818	Closed	-$118K	–	453
2021 Q2	$118K	Buy	+2,818	New	+$109K	0.01%	318

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AGF Investments LLC's MRVI Position: Q3 2021 in Review

AGF Investments LLC sold out of Maravai LifeSciences (MRVI) in Q3 2021, closing a stake of 2,818 shares — an estimated $118K sold.

AGF Investments LLC first reported a position in MRVI in Q2 2021 and held it in 1 quarter. The position peaked at $118K in Q2 2021. 228 funds tracked by Wall St. Rank hold MRVI as of Q3 2021.

AGF Investments LLC reported no remaining Maravai LifeSciences position as of Q3 2021 after selling out during the quarter.
AGF Investments LLC sold 2,818 Maravai LifeSciences shares in Q3 2021, an estimated $118K.
AGF Investments LLC first reported a position in Maravai LifeSciences in Q2 2021 and held it in 1 quarter.
AGF Investments LLC's Maravai LifeSciences position peaked at $118K in Q2 2021.
228 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2021.

Based on AGF Investments LLC's 13F filing for Q3 2021, filed 10 Nov 2021.